Dublin, Sept. 13, 2021 (GLOBE NEWSWIRE) -- The "Immunochemicals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Immunochemicals Market to Reach $5.3 Billion by 2027
Amid the COVID-19 crisis, the global market for Immunochemicals estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 5.3% over the period 2020-2027.
Catalog Antibodies, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$3.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Custom Antibodies segment is readjusted to a revised 6.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 5% CAGR
The Immunochemicals market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$929.7 Million by the year 2027 trailing a CAGR of 5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Immunochemicals - A Prelude
- Recent Market Activity
- Research Antibodies Market: Critical Role in Drug Discovery and Research
- Key Factors Influencing Purchasing Decisions
- Citations: One of the Key Factors Driving Research Antibodies' Purchase
- The US Dominates the Global Immunochemicals Market
- Emerging Markets Offer Huge Potential
- Catalog Antibodies - The Largest Market Segment
- Custom Antibodies: Finding Favor in Research Applications
- Primary Antibodies Dominate the Market
- Competitive Scenario
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
- Abcam Plc. (UK)
- Agilent Research Laboratories (USA)
- Biolegend, Inc. (USA)
- Bio-Rad Laboratories, Inc. (USA)
- Cell Signaling Technology, Inc. (USA)
- GenScript Biotech Corporation
- PerkinElmer, Inc. (USA)
- Rockland Immunochemicals, Inc. (USA)
- Santa Cruz Biotechnology, Inc. (USA)
- Merck (Sigma-Aldrich Corporation) (USA)
- Thermo Fisher Scientific Inc. (USA)
3. MARKET TRENDS & DRIVERS
- Increasing Research Funding Bolsters Market Growth
- Chinese Market to Become the Largest Investor in Basic Research
- Cancer Research Drives the Global Immunochemicals Market
- Cancer Ranks Among the Top Ten Causes of Death Worldwide
- 'Reproducibility Crisis' of Antibodies - A Major Cause of Concern
- Proper Validation of Antibodies - Vendor Do their Part
- New Technologies for Antibodies Validation
- Personalized Medicine Offers New Growth Avenues
- Rabbit Monoclonal Antibodies Score over Other Animal Antibodies
- Researchers Prefer Commercial Research to Academic Research
- Increasing Collaborations between Industry and Academia
- Beckman Coulter GmbH (USA)
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 116
For more information about this report visit https://www.researchandmarkets.com/r/iyjcoo
